source
- Roche and Eli Lilly receive FDA clearance for first blood test detecting Alzheimer’s biomarker pTau217Roche and Eli Lilly have secured FDA clearance for a new blood test that measures phosphorylated tau protein pTau217, a marker linked to amyloid plaques in Alzheimer’s disease. The Elecsys pTau217…
- FDA clears Roche and Lilly Alzheimer’s blood tests, while Regenxbio gene therapy trial halted againThe U.S. Food and Drug Administration announced it has granted clearance for blood-based diagnostic tests for Alzheimer’s disease developed by Roche and Eli Lilly. The clearances allow the compani…